站内公告:
联系我们CONTACT
2025-01-01点击量:948
本文摘要:FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities,GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains,andhasbeenfoundguiltyofbribingnon-governmentpersonnel.GSKplcfullyacceptsthefactsandevidenceoftheinvestigation,andtheverdictoftheChinesejudicialauthorities.Furthermore,GSKplcsincerelyapologisestotheChinesepatients,doctorsandhospitals,andtotheChineseGovernmentandtheChinesepeople.GSKplcdeeplyregretsthedamagecaused.GSKplcalsoapologisesfortheharmcausedtoindividualswhowereillegallyinvestigatedbyGSKCI.TheillegalactivitiesofGSKCIareaclearbreachofGSKplc’sgovernanceandcomplianceprocedures;andarewhollycontrarytothevaluesandstandardsweexpectfromouremployees.Itisdeeplydisappointingthattheseissueswerenotidentifiedandaddressed.GSKplchasreflecteddeeplyandlearnedfromitsmistakes,hastakenstepstocomprehensivelyrectifytheissuesidentifiedattheoperationsofGSKCI,andmustworkhardtoregainthetrustoftheChinesepeople.Today,GSKplcmakesafurthercommitmenttotheChinesegovernmentandpeoplethatGSKCIwilltaketangibleactionstoestablishitselfasamodelforreforminChina’shealthcareindustry:bycontinuingtoinvestinChinaandsupportingChinasscientificdevelopment;andbyfurtherdevelopmentofinnovativenewmedicinesandvaccinesfordiseasesprevalentinChina.GSKCIwillalsoincreaseaccesstoitsproductsinbothcityandruralareasofChinathroughgreaterexpansionofproductionandthroughpriceflexibility.本文来源:立即博平台-www.dgyitzn.com